Emerging Biomarker Research in NAFLD and NASH
Nonalcoholic fatty liver disease (NAFLD) affects an estimated 25% of the global population. Today, liver biopsies are the only gold standard for precise diagnosis of NAFLD. Limited diagnostic methodologies and the continual rise in NAFLD has resulted in the search for non-invasive techniques for the diagnosis and monitoring of the disease.
Download our eBook to learn about the biological changes that result from the development and progression of NAFLD. Research on utilizing blood-based biomarkers as possible non-invasive future alternatives to liver biopsies is also discussed.